TH154048A - Oxazolin-2-transfer compounds and their use as a PI3KS inhibitor - Google Patents
Oxazolin-2-transfer compounds and their use as a PI3KS inhibitorInfo
- Publication number
- TH154048A TH154048A TH1401004824A TH1401004824A TH154048A TH 154048 A TH154048 A TH 154048A TH 1401004824 A TH1401004824 A TH 1401004824A TH 1401004824 A TH1401004824 A TH 1401004824A TH 154048 A TH154048 A TH 154048A
- Authority
- TH
- Thailand
- Prior art keywords
- pl3k
- oxazolin
- transfer compounds
- transfer
- pi3ks
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title claims abstract 3
- 230000002401 inhibitory effect Effects 0.000 title claims abstract 3
- 150000001875 compounds Chemical class 0.000 title 1
- 102000003993 Phosphatidylinositol 3-Kinases Human genes 0.000 claims abstract 6
- 108090000430 Phosphatidylinositol 3-Kinases Proteins 0.000 claims abstract 6
- 201000010099 disease Diseases 0.000 claims abstract 4
- 239000000470 constituent Substances 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 230000000694 effects Effects 0.000 claims abstract 2
- 230000001419 dependent Effects 0.000 claims 1
- -1 pyrimidine compound Chemical class 0.000 claims 1
- 150000003230 pyrimidines Chemical class 0.000 abstract 1
Abstract
DC60 (13/10/57) การประดิษฐ์นี้เกี่ยวข้องกับสารประกอบไพริมิดีนที่แทนที่ออกซะโซลิดิน-2-โอนซึ่งออก ฤทธิ์ในรูปตัวยับยั้ง Pl3K (ฟอสฟาติดิลอิโนซิทอล-3-ไคเนส), อีกทั้งองค์ประกอบทางเภสัชกรรม ของสิ่งเหล่านี้, วิธีการสำหรับการผลิตและการใช้เหล่านี้สำหรับการรักษาของสภาวะ, โรค และความผิดปกติที่ขึ้นอยู่กับ Pl3K สิทธิบัตรยา DC60 (13/10/57) This invention involves pyrimidine compounds that replace oxasolidin-2-transfer, which are released. Activity in the form of inhibitors Pl3K (phosphatidylinositol-3-kinase), as well as pharmaceutical constituents Of these, methods for the production and use of these for the treatment of conditions, diseases and disorders are based on the Pl3K drug patents.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH154048A true TH154048A (en) | 2016-07-06 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018236800B2 (en) | DNA-PK inhibitors | |
| NI201600071A (en) | AUTOTAXIN INHIBITOR COMPOUNDS | |
| WO2016105525A3 (en) | Novel pyrimidines as egfr inhibitors and methods of treating disorders | |
| EA201500362A1 (en) | RHO-KINASE INHIBITORS | |
| EA201790575A1 (en) | TRIAZOLOPIRASINONS AS PDE1 INHIBITORS | |
| DOP2014000253A (en) | NAMPT INHIBITORS | |
| WO2015031679A3 (en) | Modulation of prekallikrein (pkk) expression | |
| EA201690513A1 (en) | COMBINATION OF MEK INHIBITOR AND ERK INHIBITOR FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES | |
| EA201692313A1 (en) | Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase | |
| EA201790576A1 (en) | Spirocyclic inhibitors of katepsin C | |
| EA201791259A1 (en) | DERIVATIVES OF PIPERIDINE AS HDAC1 / 2 INHIBITORS | |
| MX2016003823A (en) | A selective inhibitor of phosphatidylinositol 3-kinase-gamma. | |
| SA519410093B1 (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
| EA201690039A1 (en) | RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION | |
| NI201600070A (en) | AUTOTAXIN TETRAYCLIC INHIBITORS | |
| CL2017000006A1 (en) | Quinolizinone derivatives as pi3k inhibitors | |
| WO2012125981A3 (en) | Raf kinase inhibitors | |
| EA201792610A1 (en) | METHOD OF TREATMENT OF NEUROLOGICAL DISEASE | |
| UY35746A (en) | SUBSTITUTED PHENYLALANINE DERIVATIVES | |
| EA201691108A1 (en) | Quinazoline-THF-Amines as PDE1 Inhibitors | |
| EA201691335A1 (en) | HEXAHYDROFUROPYRROLES AS INHIBITORS PDE1 | |
| TH154048A (en) | Oxazolin-2-transfer compounds and their use as a PI3KS inhibitor | |
| DOP2015000290A (en) | BENZOXAZOLES REPLACED | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| TH153182A (en) | Beta-sequestrate inhibitors |